Clinical Trials

Study Title:
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non Muscle Invasive Bladder Cancer (BRIDGE)

For more information about the trial above please contact the study team:

Medical University of South Carolina
Affiliate Principal Investigator, Tanneru, Karthik, at tanneru@musc.edu.
Affiliate Principal Investigator, Savage, Stephen, at savages@musc.edu.
Principal Investigator, Savage, Stephen, at savages@musc.edu.
Study Coordinator, Tucker, Renee, at tuckerr@musc.edu.

Ralph H. Johnson VAMC
Study Coordinator, Jeter, Kathy, at katherine.jeter2@va.gov.
Study Coordinator, Jeter, Kathy, at katherine.jeter2@va.gov.

Trial opened at the following institutions: Medical University of South Carolina, Ralph H. Johnson VAMC